Clinical trial software startup Medable joins unicorns with $304M funding

Medable Inc., a startup whose technology helped to accelerate development of Covid-19 vaccines, nearly tripled its valuation to $2.1 billion in a large venture round. The nine-year old Palo Alto startup raised $304 million in its fourth funding in the past 18 months, a period in which it has now raised about $475 million in total. The company's software platform helps pharmaceutical developers minimize the need for in-person site visits during clinical trials . It says this helps enroll patients…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news